Clinical Trials Logo

Clinical Trial Summary

The field of artificial intelligence is booming in medicine and in the field of diagnosis. The data can be varied: x-rays, pathology sections, or photographs. It is considered that 30 to 40% of the 7000 rare diseases described to date cause craniofacial dysmorphia. Their detection sometimes requires the trained eye of a geneticist, because certain phenotypic traits are subtle. These diagnostic difficulties and the fact that certain diseases are extremely uncommon lead to considerable diagnostic delays


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06219421
Study type Observational
Source Imagine Institute
Contact Yasmine Ainouz, MD
Email yasmine.ainouz@institutimagine.org
Status Not yet recruiting
Phase
Start date March 1, 2024
Completion date March 1, 2028

See also
  Status Clinical Trial Phase
Completed NCT03563677 - Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases N/A
Completed NCT00213811 - Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults N/A
Completed NCT06225141 - Characterization and Recognition of Genetic Diseases by Photography
Recruiting NCT02743845 - Gene Discovery Core, The Manton Center